chr1-7664502-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015215.4(CAMTA1):​c.1955C>T​(p.Ser652Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00162 in 1,613,292 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S652W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 4 hom. )

Consequence

CAMTA1
NM_015215.4 missense

Scores

7
12

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.08

Publications

6 publications found
Variant links:
Genes affected
CAMTA1 (HGNC:18806): (calmodulin binding transcription activator 1) The protein encoded by this gene contains a CG1 DNA-binding domain, a transcription factor immunoglobulin domain, ankyrin repeats, and calmodulin-binding IQ motifs. The encoded protein is thought to be a transcription factor and may be a tumor suppressor. However, a translocation event is sometimes observed between this gene and the WWTR1 gene, with the resulting WWTR1-CAMTA1 oncoprotein leading to epithelioid hemangioendothelioma, a malignant vascular cancer. [provided by RefSeq, Mar 2017]
CAMTA1 Gene-Disease associations (from GenCC):
  • cerebellar dysfunction with variable cognitive and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0078443885).
BP6
Variant 1-7664502-C-T is Benign according to our data. Variant chr1-7664502-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 377146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00131 (200/152354) while in subpopulation NFE AF = 0.00243 (165/68028). AF 95% confidence interval is 0.00212. There are 1 homozygotes in GnomAd4. There are 82 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 200 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAMTA1NM_015215.4 linkc.1955C>T p.Ser652Leu missense_variant Exon 9 of 23 ENST00000303635.12 NP_056030.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAMTA1ENST00000303635.12 linkc.1955C>T p.Ser652Leu missense_variant Exon 9 of 23 1 NM_015215.4 ENSP00000306522.6

Frequencies

GnomAD3 genomes
AF:
0.00131
AC:
200
AN:
152236
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00243
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00128
AC:
320
AN:
250170
AF XY:
0.00128
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.00148
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.00223
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00165
AC:
2412
AN:
1460938
Hom.:
4
Cov.:
36
AF XY:
0.00162
AC XY:
1180
AN XY:
726796
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33480
American (AMR)
AF:
0.00136
AC:
61
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.0000762
AC:
4
AN:
52474
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.00202
AC:
2243
AN:
1112010
Other (OTH)
AF:
0.00147
AC:
89
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
158
316
474
632
790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00131
AC:
200
AN:
152354
Hom.:
1
Cov.:
33
AF XY:
0.00110
AC XY:
82
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.000216
AC:
9
AN:
41596
American (AMR)
AF:
0.00124
AC:
19
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00243
AC:
165
AN:
68028
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00189
Hom.:
3
Bravo
AF:
0.00132
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00128
AC:
156
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00273
EpiControl
AF:
0.00237

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CAMTA1: BS1 -

Nov 07, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cerebellar dysfunction with variable cognitive and behavioral abnormalities Benign:1
Oct 14, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.047
T
Eigen
Benign
0.17
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.0081
T
MetaRNN
Benign
0.0078
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.81
L
PhyloP100
4.1
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.068
Sift
Uncertain
0.0080
D
Sift4G
Uncertain
0.060
T
Polyphen
0.76
P
Vest4
0.47
MVP
0.15
MPC
0.70
ClinPred
0.033
T
GERP RS
5.1
Varity_R
0.13
gMVP
0.44
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144242373; hg19: chr1-7724562; COSMIC: COSV57893878; API